14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ALDX ranks #12354 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Aldeyra Therapeutics Stock Forecast NASDAQ:ALDX

$7.33 (6.39%)

Volume: 1M

Closed: Dec 07, 2021

Hollow Logo Score: -1.620

Aldeyra Therapeutics Stock Forecast

$7.33 (6.39%)

Volume: 1M

Closed: Dec 07, 2021

Score Hollow Logo -1.620
Which way will ALDX go? Request
Key Stats
Beta 1.31
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 80 ] RSI14 is 30 and the stock is currently not being overbought or oversold

Big movements in Aldeyra Therapeutics stock price on Tuesday moving 11.83% between high and low
(Updated on Dec 07, 2021)

Sell candidate since 2021-12-07

The Aldeyra Therapeutics stock price gained 6.39% on the last trading day (Tuesday, 7th Dec 2021), rising from $6.89 to $7.33. During the day the stock fluctuated 11.83% from a day low at $6.72 to a day high of $7.51. The price has fallen in 6 of the last 10 days and is down by -7.91% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 496 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $7.91 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.86 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.51% during the next 3 months and, with a 90% probability hold a price between $6.28 and $8.52 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 6.39%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aldeyra Therapeutics stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $8.29. On a fall, the stock will find some support from the short-term average at $7.24. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Aldeyra Therapeutics finds support from accumulated volume at $7.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.79 between high and low, or 11.83%. For the last week, the stock has had a daily average volatility of 8.42%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Aldeyra Therapeutics stock A Buy?

Aldeyra Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.620

Predicted Opening Price for Aldeyra Therapeutics of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$7.19 $7.33 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Dec 01, 2021 "SVB Leerink" gave "$24.00" rating for ALDX. The price target was changed from $7.37 to 3.9%.

Volatility and Risk
Daily Average Volatility: 8.42 %
Overall Risk: Very High High Medium Low Very Low
8.42 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $8.14
Price: $7.33
Support: $7.16

ALDX Insider Trading Show all Trades



Last 100 transactions
Buy: 11 616 349 | Sell: 96 743 (Shares)
Date Action Amount Person Type
Jun 08, 2021 Buy 13 534 Miller-rich Nancy Stock Option (Right to Buy)
Jun 08, 2021 Buy 583 Miller-rich Nancy Stock Option (Right to Buy)
Jun 08, 2021 Buy 13 534 Joyce Martin Joseph Stock Option (Right to Buy)
Jun 08, 2021 Buy 408 Joyce Martin Joseph Stock Option (Right to Buy)
Jun 08, 2021 Buy 1 750 Joyce Martin Joseph Stock Option (Right to Buy)
Show all Insider Trades


Last 100 transactions
Buy: 11 616 349 | Sell: 96 743 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 7.98 8.86 %
7.68 4.72 %
7.49 2.16 %
Current price: 7.33
Support 6.88 -6.11 %
6.69 -8.67 %
6.39 -12.81 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 8.81 20.19 %
8.57 16.92 %
8.14 11.05 %
Current price 7.33
Support 7.16 -2.32%
6.89 -6.00%
0 .

Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, focuses on the development of products for diseases caused by inflammation and inborn errors of metabolism in the United States and internationally. It is developing NS2, a small molecule designed to trap and allow for the degradation of aldehydes. Its product is used for the treatment of allergic conjunctivitis, noninfectious anterior uveitis, sjögren-larsson syndrome, and succinic semi-aldeh... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE